Analyst coverage and company performance data published regarding Jazz Pharmaceuticals, involving MarketBeat, Royal Bank of Canada, and TD Cowen.
Steady: 0 in the last 7 days
Updated nov 6
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst coverage and company performance data published regarding Jazz Pharmaceuticals, involving MarketBeat, Royal Bank of Canada, and TD Cowen.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- TD Cowen boosted its price target and gave a buy rating for Jazz Pharmaceuticals.Sub-event
Analysts raised price targets and published performance data for Jazz Pharmaceuticals.1 source
Keep exploring
The entities involved
-
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
-
TD Cowen
American investment bank
Related events
- Analyst firms TD Cowen, Freedom Capital, and Morgan Stanley provided market coverage and ratings for Norwegian Cruise Line.
- Royal Bank of Canada raised its price objective for Vertex Pharmaceuticals, with Benzinga and MarketBeat reporting related analyst changes.
- Analyst firm TD Cowen raised its price objective for Zebra Technologies stock, with the consensus data being aggregated by MarketBeat.
- Financial firms including Truist, RBC, TD Cowen, and Jefferies issued various rating updates on October 30, 2026.
- Multiple financial firms, including Morgan Stanley and TD Cowen, updated price targets and ratings for various institutions on October 31, 2026.